🕒 Thursday 4 December 2025 Thu, 4 Dec 2025
79 Articles
Critical Resources Secures Drill-Ready Cap Burn Gold Project in New Zealand
Critical Resources Limited has completed the acquisition of the Cap Burn Gold Project in New Zealand, securing key permits and land access to launch its inaugural drilling program in a highly prospective gold region.
4 Dec
Maxwell Dee
Argenica’s ARG-007 Clears Key FDA Hurdle with Tenecteplase Compatibility
Argenica Therapeutics has demonstrated that its lead drug candidate ARG-007 does not interfere with the clot-busting agent tenecteplase, fulfilling a critical FDA requirement and advancing its stroke therapy development.
4 Dec
Ada Torres
Cash Converters Expands East Coast Reach with $37.1m Franchise Buyout
Cash Converters has completed a $37.1 million acquisition of 29 franchise stores across Australia’s East Coast, aiming to boost earnings and operational efficiency from year one.
4 Dec
Claire Turing
Meeka Metals Uncovers High-Grade Gold at Rosapenna, Expands Murchison Potential
Meeka Metals’ initial exploration drilling at the new Rosapenna target within the Fairway shear zone reveals significant high-grade gold intersections, underscoring the potential for resource growth at the Murchison Gold Project.
4 Dec
Maxwell Dee
Lefroy Exploration Launches Mining at Lucky Strike, Eyes March 2026 Gold Output
Lefroy Exploration has officially started mining operations at its Lucky Strike Gold Deposit near Kalgoorlie, with first ore expected by late December and gold production targeted for March 2026.
4 Dec
Maxwell Dee
True North Copper Advances Cloncurry Project with New Pre-Feasibility Study
True North Copper has launched a right-sized Pre-Feasibility Study for its Cloncurry Copper Project following strong 2025 drilling results, aiming to refine resource estimates and optimise development plans ahead of a potential investment decision in 2026.
4 Dec
Maxwell Dee
Pacific Edge Taps Simon Flood to Lead Amid Medicare Reimbursement Hurdles
Pacific Edge appoints Simon Flood as chairman designate, aiming to leverage his global investment expertise to navigate Medicare reimbursement challenges for its bladder cancer diagnostic tests in the US.
4 Dec
Ada Torres